High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment
CD8+CD161+ T-cells exhibit augmented memory and cytolytic properties, mediating enhanced immunity in murine tumor models and improved survival in human non-small cell lung cancer. This T-cell subset might serve as a biomarker of positive response to th…